Viewing Study NCT06090656


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-02 @ 3:11 PM
Study NCT ID: NCT06090656
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2023-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module